Dear ISPOR Colleague, 

Recently The Belgian healthcare payer INAMI/RIZIV has commissioned work to explore the potential of real-world evidence to close evidentiary gaps for HTA/payer decisions. Following six months of work by a multi-stakeholder group, version 1.0 of the report Real-world evidence to support HTA/payer decisions on highly innovative technologies - Actions for stakeholders is issued for consultation. You can access the paper here.

ISPOR is collecting comments for response. The comments should be focused on the proposed actions for stakeholders in sections 4 and 5 by entering your answers in the comment boxes below. 

We request that enter your survey responses by December 10th if you would like your responses to be considered.

Question Title

* 1. State any suggested alterations or additions to the proposed actions in sections 4 of the paper, by referring to the number of the recommended action.

Question Title

* 2. State any suggested alterations or additions to the proposed actions in sections 5 of the paper, by referring to the number of the recommended action.

Question Title

* 3. Are there any initiatives underway that would support implementation of the recommendations?

Question Title

* 4. Do you know of any mechanisms that could support the development of the proposed multi-stakeholder learning network - recommendation 9.0?

T